Top MarketRank™ StocksTop MarketRank™NYSE:MDT Medtronic (MDT) Stock Price, News & Analysis $85.89 -0.07 (-0.08%) As of 09:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Medtronic Stock (NYSE:MDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medtronic alerts:Sign Up Key Stats Today's Range$86.25▼$86.2550-Day Range$80.70▼$88.4752-Week Range$75.96▼$96.25Volume376,197 shsAverage Volume7.70 million shsMarket Capitalization$110.16 billionP/E Ratio23.73Dividend Yield3.26%Price Target$97.87Consensus RatingModerate Buy Company OverviewMedtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.Written by Jeffrey Neal JohnsonRead More… Medtronic Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks98th Percentile Overall ScoreMDT MarketRank™: Medtronic scored higher than 98% of companies evaluated by MarketBeat, and ranked 22nd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingMedtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageMedtronic has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Medtronic's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth6.78% Earnings GrowthEarnings for Medtronic are expected to grow by 6.78% in the coming year, from $5.46 to $5.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medtronic is 23.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Medtronic is 23.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.73.Price to Earnings Growth RatioMedtronic has a PEG Ratio of 2.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedtronic has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medtronic's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.62% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently decreased by 42.19%, indicating that investor sentiment is improving significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldMedtronic pays a meaningful dividend of 3.24%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMedtronic has been increasing its dividend for 49 years.Dividend CoverageThe dividend payout ratio of Medtronic is 77.35%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Medtronic will have a dividend payout ratio of 48.03% next year. This indicates that Medtronic will be able to sustain or increase its dividend.Read more about Medtronic's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.26 Percentage of Shares Shorted0.62% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently decreased by 42.19%, indicating that investor sentiment is improving significantly. News and Social Media3.5 / 5News Sentiment1.26 News SentimentMedtronic has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 51 news articles for Medtronic this week, compared to 35 articles on an average week.Search InterestOnly 42 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -11% compared to the previous 30 days.MarketBeat Follows28 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 8% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Medtronic insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.20% of the stock of Medtronic is held by insiders.Percentage Held by Institutions82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medtronic's insider trading history. Receive MDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter. Email Address MDT Stock News HeadlinesIntuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars? (MDT)Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?June 19, 2025 | marketbeat.com3 Stocks With 3% to 9% Yields Just Raised Dividends Again (MDT)June 2, 2025 | dividendstocks.comIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't have happened at a worse time. Trump is already dealing with Biden's $34 trillion debt bomb AND now a Middle East war. This is exactly what the "resistance" has been waiting for.June 24, 2025 | American Alternative (Ad)Medtronic (MDT) Expands Board with New AppointmentJune 23 at 8:52 PM | gurufocus.comMedtronic Board appoints Dr. Joon Lee as a new directorJune 23 at 4:15 PM | prnewswire.com2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in JuneJune 22 at 5:25 AM | fool.comDecoding Medtronic PLC (MDT): A Strategic SWOT InsightJune 21 at 5:49 PM | gurufocus.comBoston Scientific, Medtronic, Constellation, Abbott, EOG Trending by AnalystsJune 21 at 5:08 AM | tipranks.comSee More Headlines MDT Stock Analysis - Frequently Asked Questions How have MDT shares performed this year? Medtronic's stock was trading at $79.88 at the beginning of 2025. Since then, MDT stock has increased by 7.7% and is now trading at $86.02. View the best growth stocks for 2025 here. How were Medtronic's earnings last quarter? Medtronic PLC (NYSE:MDT) announced its quarterly earnings data on Wednesday, May, 21st. The medical technology company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.04. The firm's quarterly revenue was up 3.9% compared to the same quarter last year. Read the conference call transcript. Who are Medtronic's major shareholders? Top institutional shareholders of Medtronic include Vanguard Group Inc. (9.75%), Massachusetts Financial Services Co. MA (1.74%), Bank of New York Mellon Corp (1.61%) and Deutsche Bank AG (1.48%). Insiders that own company stock include Geoffrey Martha, Sean Salmon, Gregory L Smith, Hoedt Rob Ten, Brett A Wall and Michael Marinaro. View institutional ownership trends. How do I buy shares of Medtronic? Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medtronic own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medtronic investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Meta Platforms (META), NVIDIA (NVDA), Chevron (CVX), Verizon Communications (VZ) and Broadcom (AVGO). Company Calendar Record date for 4/11 Dividend3/28/2025Ex-Dividend for 4/11 Dividend3/28/2025Dividend Payable4/11/2025Last Earnings5/21/2025Today6/23/2025Record date for 7/11 Dividend6/27/2025Ex-Dividend for 7/11 Dividend6/27/2025Dividend Payable7/11/2025Next Earnings (Estimated)8/19/2025Fiscal Year End4/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNYSE:MDT CIK1613103 Webwww.medtronic.com Phone(531) 438-1700Fax763-514-4879Employees95,000Year Founded1949Price Target and Rating Average Stock Price Target$97.87 High Stock Price Target$110.00 Low Stock Price Target$87.00 Potential Upside/Downside+13.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage18 Analysts Profitability EPS (Most Recent Fiscal Year)$3.62 Trailing P/E Ratio23.76 Forward P/E Ratio15.75 P/E Growth2.33Net Income$4.66 billion Net Margins13.90% Pretax Margin16.78% Return on Equity14.54% Return on Assets7.83% Debt Debt-to-Equity Ratio0.53 Current Ratio1.85 Quick Ratio1.42 Sales & Book Value Annual Sales$33.54 billion Price / Sales3.29 Cash Flow$7.72 per share Price / Cash Flow11.14 Book Value$37.62 per share Price / Book2.29Miscellaneous Outstanding Shares1,282,540,000Free Float1,279,978,000Market Cap$110.32 billion OptionableOptionable Beta0.79 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NYSE:MDT) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medtronic PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Medtronic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.